Matthew Ronsheim - Oct 19, 2021 Form 4 Insider Report for Entasis Therapeutics Holdings Inc. (ETTX)

Role
Chief of Pharmaceutical Sciences and Manufacturing
Signature
Elizabeth M. Keiley as Attorney-in-Fact for Matthew Ronsheim
Stock symbol
ETTX
Transactions as of
Oct 19, 2021
Transactions value $
-$11,991
Form type
4
Date filed
10/20/2021, 04:05 PM
Previous filing
Feb 15, 2022
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETTX Common Stock Award $0 +25K +100% $0.00 50K Oct 19, 2021 Direct F1
transaction ETTX Common Stock Sale -$12K -3.76K -7.52% $3.19 46.2K Oct 19, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as a result of the satisfaction of the performance criteria of the underlying award as of the date stated. Fifty percent of this award vested on such date and the remaining fifty percent will vest on the first anniversary of such date, subject to the reporting person's continued employment with the Company.
F2 Represents shares sold solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on October 19, 2021. The number of shares sold was determined based on the closing price on the last trading day prior to vesting, which was October 18, 2021.

Remarks:

Chief of Pharmaceutical Sciences and Manufacturing